Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...

Novo Nordisk will be initiating a Phase IIb trial of monlunabant to answer some questions about the drug before initiating a pivotal study. Image credit: Shutterstock / Kittyfly. Questions remain over ...

The patients in the trial had previously undergone endocrine-based therapy and at least one other systemic therapy. Credit: Maria Sbytova / Shutterstock. AstraZeneca and Daiichi Sankyo have reported ...

Olanzapine is an atypical antipsychotic and was first approved by the US Food and Drug Administration in 2009 by Eli Lilly. Image credit: Jonathan Weiss / Shutterstock. Teva Pharmaceuticals has shared ...

Summit Therapeutics and Akeso published results for the Phase III HARMONi-2 trial, which tested ivonescimab, a bispecific ...

The lead asset is being developed for treating Group 2 pulmonary hypertension-heart failure with preserved ejection fraction. Credit: sasirin pamai / Shutterstock. Tectonic Therapeutic has reported ...

The trial enrolled 102 patients with metabolic-dysfunction-associated steatohepatitis. Credit: Emily frost / Shutterstock. Aligos Therapeutics has announced positive topline results from the Phase IIa ...

In Part A of the CIRRUS-HCM trial, patients with obstructive HCM received a single dose of 50, 100, or 200mg of EDG-7500. Credit: Inside Creative House/Shutterstock. Edgewise Therapeutics has ...

IVL uses sonic pressure waves to break up calcium deposits in coronary arteries. Image credit: Shutterstock / Marisa Maneesang. The market for intravascular lithotripsy (IVL), a procedure utilised to ...

Last year, the US Food and Drug Administration (FDA) placed a partial clinical hold on Phase III trials evaluating tolebrutinib in MS and myasthenia gravis, including the HERCULES study. Image credit: ...